Terms: = Cervical cancer AND PTEN, MMAC1, 5728, MGC11227, PTEN1, MHAM, P60484, BZS, ENSG00000171862 AND Treatment
68 results:
1. Phase I Study of mTORC1/2 Inhibitor Sapanisertib (CB-228/TAK-228) in Combination with Metformin in Patients with mTOR/AKT/PI3K Pathway Alterations and Advanced Solid Malignancies.
Subbiah V; Coleman N; Piha-Paul SA; Tsimberidou AM; Janku F; Rodon J; Pant S; Dumbrava EEI; Fu S; Hong DS; Zhang S; Sun M; Jiang Y; Roszik J; Song J; Yuan Y; Meric-Bernstam F; Naing A
Cancer Res Commun; 2024 Feb; 4(2):378-387. PubMed ID: 38126764
[TBL] [Abstract] [Full Text] [Related]
2. Knockdown of miR-24 Suppressed the Tumor Growth of cervical Carcinoma Through Regulating pten/PI3K/AKT Signaling Pathway.
He H; Lin C; Lu Y; Wu H
Biochem Genet; 2024 Apr; 62(2):1277-1290. PubMed ID: 37589947
[TBL] [Abstract] [Full Text] [Related]
3. Clinical availability and characteristics of multigene panel testing for recurrent/advanced gynecologic cancer.
Kitazawa S; Chiyoda T; Nakamura K; Sakai K; Yoshihama T; Nishio H; Kobayashi Y; Iwata T; Banno K; Yamagami W; Nishihara H; Aoki D
Int J Clin Oncol; 2023 Nov; 28(11):1554-1562. PubMed ID: 37574505
[TBL] [Abstract] [Full Text] [Related]
4. miR-19-3p Targets pten to Regulate cervical cancer Cell Proliferation, Invasion, and Autophagy.
Wang W; Liu L; Tian Y
Genet Res (Camb); 2023; 2023():4784500. PubMed ID: 36908850
[TBL] [Abstract] [Full Text] [Related]
5. Machine learning for genetic prediction of chemotherapy toxicity in cervical cancer.
Guo L; Wang W; Xie X; Wang S; Zhang Y
Biomed Pharmacother; 2023 May; 161():114518. PubMed ID: 36906972
[TBL] [Abstract] [Full Text] [Related]
6.
Flores Legarreta A; Salvo G; Gonzales NR; Chisholm G; Hillman RT; Frumovitz M
J Gynecol Oncol; 2023 Jul; 34(4):e50. PubMed ID: 36807750
[TBL] [Abstract] [Full Text] [Related]
7. ROS1 as a possible prognostic biomarker of cervical adenocarcinoma: An exploratory analysis with next-generation sequencing.
Machida H; Matsuo K; Tanaka M; Kitatani K; Takase A; Yokoyama K; Kajiwara H; Yasaka M; Ikeda M; Yoshida H; Hirasawa T; Mikami M
Gynecol Oncol; 2023 Apr; 171():59-66. PubMed ID: 36804622
[TBL] [Abstract] [Full Text] [Related]
8. Foxo3a-Mediated DNMT3B Impedes cervical cancer Cell Proliferation and Migration Capacities through Suppressing pten Promoter Methylation.
Li H; Yuan Y; Dong H; Wang T; Zhang D; Zhou L; Chen L; He X
J Invest Surg; 2023 Dec; 36(1):2162170. PubMed ID: 36653180
[TBL] [Abstract] [Full Text] [Related]
9. LncRNA MEG3 promotes cisplatin sensitivity of cervical cancer cells by regulating the miR-21/pten axis.
Du Y; Geng G; Zhao C; Gao T; Wei B
BMC Cancer; 2022 Nov; 22(1):1145. PubMed ID: 36344947
[TBL] [Abstract] [Full Text] [Related]
10. An integrative approach toward identification and analysis of therapeutic targets involved in HPV pathogenesis with a focus on carcinomas.
Gupta AK; Kumar M
Cancer Biomark; 2023; 36(1):31-52. PubMed ID: 36245368
[TBL] [Abstract] [Full Text] [Related]
11. Small Cell and Other Rare Histologic Types of cervical cancer.
Marchocki Z; Swift B; Covens A
Curr Oncol Rep; 2022 Nov; 24(11):1531-1539. PubMed ID: 35947285
[TBL] [Abstract] [Full Text] [Related]
12. Navigating through perplex morphologic changes after exogenous hormone usage.
Chang RJ; Rivera-Colon G; Chen H; Niu S; Carrick K; Lucas E; Gwin K; Zheng W
Semin Diagn Pathol; 2022 May; 39(3):148-158. PubMed ID: 34782217
[TBL] [Abstract] [Full Text] [Related]
13. Circular RNA hsa_circ_0000730 restrains cell proliferation, migration, and invasion in cervical cancer through miR-942-5p/pten axis.
Yuan DD; Jia CD; Yan MY; Wang J
Kaohsiung J Med Sci; 2021 Nov; 37(11):964-972. PubMed ID: 34562344
[TBL] [Abstract] [Full Text] [Related]
14. Roles of autophagy in relation to mitochondrial stress responses of HeLa cells to lamellarin cytotoxicity.
Sopha P; Phutubtim N; Chantrathonkul B; Ploypradith P; Ruchirawat S; Chittchang M
Toxicology; 2021 Oct; 462():152963. PubMed ID: 34560126
[TBL] [Abstract] [Full Text] [Related]
15. Genomic profiling of advanced cervical cancer to predict response to programmed death-1 inhibitor combination therapy: a secondary analysis of the CLAP trial.
Huang X; He M; Peng H; Tong C; Liu Z; Zhang X; Shao Y; Zhu D; Zhang J; Yin JC; Yang F; Lan C
J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34011535
[TBL] [Abstract] [Full Text] [Related]
16. Combined and selective miR-21 silencing and doxorubicin delivery in cancer cells using tailored DNA nanostructures.
Raniolo S; Unida V; Vindigni G; Stolfi C; Iacovelli F; Desideri A; Biocca S
Cell Death Dis; 2021 Jan; 12(1):7. PubMed ID: 33414439
[TBL] [Abstract] [Full Text] [Related]
17. Apigenin 7-O-glucoside promotes cell apoptosis through the pten/PI3K/AKT pathway and inhibits cell migration in cervical cancer HeLa cells.
Liu MM; Ma RH; Ni ZJ; Thakur K; Cespedes-Acuña CL; Jiang L; Wei ZJ
Food Chem Toxicol; 2020 Dec; 146():111843. PubMed ID: 33152472
[TBL] [Abstract] [Full Text] [Related]
18. Phase I Basket Study of Taselisib, an Isoform-Selective PI3K Inhibitor, in Patients with
Jhaveri K; Chang MT; Juric D; Saura C; Gambardella V; Melnyk A; Patel MR; Ribrag V; Ma CX; Aljumaily R; Bedard PL; Sachdev JC; Dunn L; Won H; Bond J; Jones S; Savage HM; Scaltriti M; Wilson TR; Wei MC; Hyman DM
Clin Cancer Res; 2021 Jan; 27(2):447-459. PubMed ID: 33148674
[TBL] [Abstract] [Full Text] [Related]
19. Glutaminase Inhibitors Induce Thiol-Mediated Oxidative Stress and Radiosensitization in treatment-Resistant cervical cancers.
Rashmi R; Jayachandran K; Zhang J; Menon V; Muhammad N; Zahner M; Ruiz F; Zhang S; Cho K; Wang Y; Huang X; Huang Y; McCormick ML; Rogers BE; Spitz DR; Patti GJ; Schwarz JK
Mol Cancer Ther; 2020 Dec; 19(12):2465-2475. PubMed ID: 33087507
[TBL] [Abstract] [Full Text] [Related]
20. LINC00673 exerts oncogenic function in cervical cancer by negatively regulating miR-126-5p expression and activates pten/PI3K/AKT signaling pathway.
Shi WJ; Liu H; Ge YF; Wu D; Tan YJ; Shen YC; Wang H; Xu H
Cytokine; 2020 Dec; 136():155286. PubMed ID: 32950808
[TBL] [Abstract] [Full Text] [Related]
[Next]
